BDXB

Q: What is the price of Becton Dickinson (BDXB) today?

The price of Becton Dickinson (BDXB) today is $ 0.00, with return of 0% compared to the last year. The price of Becton Dickinson (BDXB) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Becton Dickinson (BDXB) and international markets.

Q: When does Becton Dickinson (BDXB) pay dividends?

Becton Dickinson (BDXB) did not distribute dividends in the last year.

Q: Is Becton Dickinson (BDXB) worth it?

Currently, Becton Dickinson (BDXB) is priced at $ 0.00, with a P/E of 8.70%, representando um desvio de 870% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Becton Dickinson (BDXB) stock?

Investing in stocks of Becton Dickinson (BDXB) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Becton Dickinson (BDXB) yield today?

The yield of Becton Dickinson (BDXB) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Becton Dickinson (BDXB) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Becton Dickinson and Company

Price

$ -

return (12m)

0.00%

p/e

8.70

p/bv

0.53

DIVIDEND YIELD

0.00%

price BDXB

BDXB

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of BDXB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BDXB

review the fundamentals of Becton Dickinson shares

P/E

8.70

Sector: -2.16 Industry: -0.67

P/SALES RATIO (PSR)

0.73

Sector: 1.99 Industry: 2.51

P/BV

0.53

Sector: 2.12 Industry: 2.30

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

2.89%

Sector: -26.99% Industry: -25.01%

ROE

6.12%

Sector: -30.03% Industry: -30.75%

ROIC

Sector: -414.93% Industry: -73.73%

NET MARGIN

8.36%

Sector: -27.97% Industry: -29.36%

GROSS MARGIN

59.00%

Sector: 44.10% Industry: 50.75%

OPERATING MARGIN

10.99%

Sector: -24.33% Industry: -25.70%

P/EBITDA

6.47

Sector: -0.32 Industry: 1.47

P/EBIT

-104.41

Sector: -2.46 Industry: -1.00

P/ASSET

0.25

Sector: 1.19 Industry: 1.27

BVPS

90.45

Sector: 3.38 Industry: 4.47

EPS

5.53

Sector: -0.89 Industry: -0.87

EQUITY RATIO

0.47

Sector: 0.43 Industry: 0.45

CAGR REVENUE 5 YEARS

0.65%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.85%

Sector: - Industry: -

FAIR VALUE OF Becton Dickinson ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals BDXB

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	51.55	39.80	77.20%	0.55%	$ 949.16 B	30.99%
ISRG	72.99	11.76	16.12%	0.00%	$ 200.49 B	28.58%
TMO	33.80	4.34	12.84%	0.29%	$ 222.07 B	15.02%
SNY	10.79	1.50	13.90%	4.46%	$ 121.64 B	14.83%
MDT	27.23	0.00	0.00%	2.79%	$ 129.74 B	13.71%
NVS	17.04	5.48	32.16%	3.04%	$ 245.20 B	25.53%
ABT	15.34	4.18	27.26%	1.89%	$ 214.39 B	31.88%
CVS	211.13	1.35	0.64%	3.41%	$ 99.02 B	0.12%
GSK	12.93	4.43	34.29%	3.52%	$ 94.37 B	17.23%
BSX	51.42	0.00	0.00%	0.00%	$ 143.58 B	14.43%
TMDX	48.51	12.53	25.84%	0.00%	$ 4.45 B	16.20%
HCA	18.03	-52.99	-293.84%	0.57%	$ 114.40 B	8.53%
IDXX	56.52	37.20	65.81%	0.00%	$ 58.07 B	24.65%
INMD	5.92	1.36	22.89%	0.00%	$ 885.78 M	41.04%
DHR	46.15	3.17	6.86%	0.54%	$ 161.67 B	14.43%
RMD	25.40	5.97	23.49%	0.88%	$ 36.52 B	27.35%
FMS	16.76	0.84	5.00%	3.36%	$ 13.67 B	3.73%
PHG	115.12	2.09	1.81%	3.25%	$ 25.92 B	1.14%
HUM	21.11	1.47	6.95%	1.56%	$ 27.25 B	1.02%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

BDXB Historical Dividends

current DY: 0.00%

5-year average DY: 3.08%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	02/15/2023	03/01/2023	0,75000000
Dividend	11/15/2022	12/01/2022	0,75000000
Dividend	08/15/2022	09/01/2022	0,75000000
Dividend	05/15/2022	06/01/2022	0,75000000
Dividend	02/15/2022	03/01/2022	0,75000000
Dividend	11/15/2021	12/01/2021	0,75000000
Dividend	08/15/2021	09/01/2021	0,75000000
Dividend	05/15/2021	06/01/2021	0,75000000
Dividend	02/15/2021	03/01/2021	0,75000000
Dividend	11/15/2020	12/01/2020	0,75000000
Dividend	08/15/2020	09/01/2020	0,79170000

ABOUT THE COMPANY Becton Dickinson

Becton Dickinson and Company

Average user rating I10

4.0 (11 people)

United States

119 years

Founded: 1906

1963

Time since IPO - 62 years

72.000

Employees

The Company Becton Dickinson and Company (United States), is listed on NYSE with a market cap of $ 13.68 Billions, having an equity of $ 25.69 Billions.

With a total of 72.000 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 18.81 Billions, which generated a profit in the amount of $ 1.57 Billion.

As for its main indicators, the Company has a P/E ratio of 8.70, a P/BV ratio of 0.53 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker BDXB.

Market cap

$ 13.68 Billions

Equity

$ 25.69 Billions

US$ 25,689,000,000.00

Assets

$ 54.39 Billions

US$ 54,394,000,000.00

Total Shares Outstanding

284.01 Millions

284,014,000

Average Daily Trading Volume

$ 457.74 Thousand

US$ 457,743.14

Sector

Health

Industry

Medical Supplies and Equipment

BDXB

BDXB revenue and profits

Financial Results BDXB

DRAG THE FRAME TO SEE MORE DATA

BDXB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.86 38,88% (12M)

P/E

211.13

3.41%

ROE

0.64%

P/BV

1.35

CI - Cigna

$ 278.35 --15,24% (12M)

P/E

12.03

2.13%

ROE

14.63%

P/BV

1.76

CNC - Centene

$ 39.46 --34,16% (12M)

P/E

-3.39

0.00%

ROE

-25.12%

P/BV

0.85

HUM - Humana

$ 245.99 --15,59% (12M)

P/E

21.11

1.56%

ROE

6.95%

P/BV

1.47

SNY - Sanofi

$ 50.03 7,24% (12M)

P/E

10.79

4.46%

ROE

13.90%

P/BV

1.50

HCA - HCA Healthcare

$ 514.76 58,85% (12M)

P/E

18.03

0.57%

ROE

-293.84%

P/BV

-52.99

LLY - Eli Lilly

$ 1,104.34 40,12% (12M)

P/E

51.55

0.55%

ROE

77.20%

P/BV

39.80

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 79.86 38,88% (12 M)

P/L

211.13

3.41%

ROE

0.64%

P/VP

1.35

CI - Cigna

$ 278.35 --15,24% (12 M)

P/L

12.03

2.13%

ROE

14.63%

P/VP

1.76

CNC - Centene

$ 39.46 --34,16% (12 M)

P/L

-3.39

0.00%

ROE

-25.12%

P/VP

0.85

HUM - Humana

$ 245.99 --15,59% (12 M)

P/L

21.11

1.56%

ROE

6.95%

P/VP

1.47

SNY - Sanofi

$ 50.03 7,24% (12 M)

P/L

10.79

4.46%

ROE

13.90%

P/VP

1.50

HCA - HCA Healthcare

$ 514.76 58,85% (12 M)

P/L

18.03

0.57%

ROE

-293.84%

P/VP

-52.99

LLY - Eli Lilly

$ 1,104.34 40,12% (12 M)

P/L

51.55

0.55%

ROE

77.20%

P/VP

39.80

Frequently Asked Questions

What is the price of Becton Dickinson (BDXB) today?

The price of Becton Dickinson (BDXB) today is $ 0.00, with return of 0% compared to the last year. The price of Becton Dickinson (BDXB) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Becton Dickinson (BDXB) and international markets.

When does Becton Dickinson (BDXB) pay dividends?

Becton Dickinson (BDXB) did not distribute dividends in the last year.

Is Becton Dickinson (BDXB) worth it?

Currently, Becton Dickinson (BDXB) is priced at $ 0.00, with a P/E of 8.70%, representando um desvio de 870% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Becton Dickinson (BDXB) stock?

Investing in stocks of Becton Dickinson (BDXB) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Becton Dickinson (BDXB) yield today?

The yield of Becton Dickinson (BDXB) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Becton Dickinson (BDXB) today, the total investment would be $ 0.00, based on the current price of $ 0.00.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.00
In 5 years: $ 0.00
In 10 years: $ 0.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

BDXB

Becton Dickinson and Company

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of BDXB

review the fundamentals of Becton Dickinson shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 3.08%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Becton Dickinson

Becton Dickinson and Company

United States

119 years

1963

72.000

PROFIT X PRICE BDXB

Financial Results BDXB

BDXB cash flow

asset growth - BDXB

BDXB balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions